VAB-6 - AN EFFECTIVE CHEMOTHERAPY REGIMEN FOR PATIENTS WITH GERM-CELL TUMORS

被引：197

作者：

BOSL, GJ

GLUCKMAN, R

GELLER, NL

GOLBEY, RB

WHITMORE, WF

HERR, H

SOGANI, P

MORSE, M

MARTINI, N

BAINS, M

MCCORMACK, P

机构：

[1] MEM SLOAN KETTERING CANC CTR,DEPT MED,SOLID TUMOR SERV,NEW YORK,NY 10021

[2] MEM SLOAN KETTERING CANC CTR,UROL SERV,NEW YORK,NY 10021

[3] MEM SLOAN KETTERING CANC CTR,DEPT SURG,THORAC SERV,NEW YORK,NY 10021

[4] CORNELL UNIV,MED CTR,COLL MED,DEPT MED,NEW YORK,NY 10021

[5] CORNELL UNIV,MED CTR,COLL MED,DEPT SURG,NEW YORK,NY 10021

[6] MEM HOSP CANC & ALLIED DIS,DEPT EPIDEMIOL & BIOSTAT,NEW YORK,NY 10021

来源：

关键词：

D O I：

10.1200/JCO.1986.4.10.1493

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1493 / 1499

页数：7

共 35 条

[1] BOSL GJ, 1983, CANCER RES, V43, P3403
[2] VINBLASTINE, BLEOMYCIN AND CIS-DIAMMINEDICHLOROPLATINUM IN THE TREATMENT OF ADVANCED TESTICULAR-CARCINOMA - POSSIBLE IMPORTANCE OF LONGER INDUCTION AND SHORTER MAINTENANCE SCHEDULES
BOSL, GJ
LANGE, PH
FRALEY, EE
NOCHOMOVITZ, LE
ROSAI, J
VOGELZANG, NJ
JOHNSON, K
GOLDMAN, A
KENNEDY, BJ
[J]. AMERICAN JOURNAL OF MEDICINE, 1980, 68 (04) : 492 - 496
[3] ROLE OF ETOPOSIDE-BASED CHEMOTHERAPY IN THE TREATMENT OF PATIENTS WITH REFRACTORY OR RELAPSING GERM-CELL TUMORS
BOSL, GJ
YAGODA, A
GOLBEY, RB
WHITMORE, W
HERR, H
SOGANI, P
MORSE, M
VOGELZANG, N
MACDONALD, G
[J]. AMERICAN JOURNAL OF MEDICINE, 1985, 78 (03) : 423 - 428
[4] BOSL GJ, 1983, CANCER-AM CANCER SOC, V51, P2121, DOI 10.1002/1097-0142(19830601)51:11<2121::AID-CNCR2820511128>3.0.CO
[5] 2-2
[6] THE ROLE OF SURGERY FOLLOWING CHEMOTHERAPY IN STAGE-III GERM-CELL NEOPLASMS
BRACKEN, RB
JOHNSON, DE
FRAZIER, OH
LOGOTHETIS, CJ
TRINDADE, A
SAMUELS, ML
[J]. JOURNAL OF UROLOGY, 1983, 129 (01) : 39 - 43
[7] CHENG E, 1978, CANCER, V42, P2162, DOI 10.1002/1097-0142(197811)42:5<2162::AID-CNCR2820420512>3.0.CO
[8] 2-I
[9] CYTOREDUCTIVE SURGERY FOR METASTATIC TESTIS CANCER - CONSIDERATIONS OF TIMING AND EXTENT
DONOHUE, JP
EINHORN, LH
WILLIAMS, SD
[J]. JOURNAL OF UROLOGY, 1980, 123 (06) : 876 - 880
[10] EINHORN LH, 1979, CANCER TREAT REP, V63, P1659